JOSÉ M. LÓPEZ, M.D.; CARLOS B. FARDELLA, M.D.
To the editor: Bromocriptine, acting as a dopaminergic agonist, reduces the secretion of prolactin by the pituitary gland (1) and can also reduce the size of prolactinomas through a reduction of cytoplasmatic cell volume and tumoral cell population (2, 3). The usual dose of bromocriptine as a treatment for prolactinomas is from 5.0 to 10.0 mg/24 h. We report the case of a man with a prolactinoma who drastically reduced his serum prolactin level when treated with minimal doses of bromocriptine.
A 55-year-old man was seen in December 1983 because of lack of libido, but was otherwise asymptomatic. His serum
JOSÉ M. LÓPEZ, CARLOS B. FARDELLA. Bromocriptine Therapy and Hyperprolactinemia. Ann Intern Med. 1987;106:909–910. doi: 10.7326/0003-4819-106-6-909_2
Download citation file:
Published: Ann Intern Med. 1987;106(6):909-910.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use